Safety and efficacy of low-dose non-vitamin K antagonist oral anticoagulants versus warfarin after left atrial appendage closure with the Watchman device

Safety and efficacy of low-dose non-vitamin K antagonist oral anticoagulants versus warfarin after left atrial appendage closure with the Watchman device

Background/Purpose: Anticoagulant therapy is suggested within 45 days after Watchman device implantation for stroke prevention in patients with atrial fibrillation (AF). A previous study demonstrated that non-vitamin K antagonist oral anticoagulants (NOACs) were a feasible peri- and postprocedural a...

Full description

Bibliographic Details
Main Authors: Guohua Fu, Binhao Wang, Bin He, Yibo Yu, Zhao Wang, Mingjun Feng, Jing Liu, Xianfeng Du, Weidong Zhuo, Huimin Chu
Format: Article
Language:English
Published: Elsevier 2022-08-01
Series:Journal of the Formosan Medical Association
Subjects:
Left atrial appendage closure
Watchman device
Non-vitamin K antagonist Oral anticoagulants
Low-dose
Thromboembolic event
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664621004873

Internet

http://www.sciencedirect.com/science/article/pii/S0929664621004873

Similar Items